免疫吸附作为耐火性异常性炎症性肌肉病的新疗法:一个回顾性观察性研究
Kastriot Kastrati1, Thomas Karonitsch1, Hanien Rajab1
1Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Rheumatology (Oxford, England)
|May 28, 2025
概括
免疫吸附 (IAS) 在耐火性异常性炎症性肌肉病 (IIM) 中表现有前途. 这种疗法有效地降低了对标准治疗无反应的患者的肌酸激酶 (CK) 水平和葡萄糖皮质激素 (GC) 依赖.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 异形性炎症性肌肉病变 (IIM) 是一种自身免疫性疾病,导致肌肉炎症,肌酸激酶 (CK) 升高和残疾.
- 目前的免疫调节疗法,包括葡萄糖皮质激素 (GC),往往无法预防疾病的进展,导致耐火性疾病.
- 需要为依赖于GC或经历疾病进展的耐火IIM患者提供有效的治疗方法.
研究的目的:
- 评估免疫吸附 (IAS) 作为成年患者耐火性异常性炎症性肌肉病变 (IIM) 的辅助疗法的疗效和安全性.
- 评估IAS对肌酸激酶 (CK) 水平,葡萄糖皮质体 (GC) 剂量和患者报告结果的影响.
主要方法:
- 一项回顾性,单心研究包括23名已确认IIM耐标准疗法 (GC和疾病修饰性抗风湿药物) 的成年患者.
- 患者在2000年1月至2021年9月期间接受了免疫吸附 (IAS).
- 主要终点:12周后GC剂量和CK水平降低≥20%,患者的自我评估评价为"没有变化"或"更好". 二级终点包括4周,8周和12周的中度和重大改善. 在IAS后的3个月内,监测复发率.
主要成果:
- 52.2%的患者在12周内实现了主要终点.
- 观察到CK水平和GC剂量的显著降低,患者比较自我评估 (PCSA) 的改善.
- 在IAS后3个月内观察到较低的复发率 (18%),没有意外的不良事件发生.
结论:
- 免疫吸附 (IAS) 似乎是一种有效的辅助疗法,用于耐火性异常性炎症性肌肉病 (IIM),对传统治疗无反应.
- IAS促进了CK水平的快速降低,减少了对葡萄糖皮质激素 (GC) 的依赖,并改善了肌肉功能和患者报告的结果.
- IAS为管理耐火性IIM提供了一个潜在的治疗选择,改善患者的治疗结果和生活质量.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495
Inflammatory Bowel Disease IV: Pharmacological Management
531
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
531
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
644
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
644

